Now Or Never to receive a one-night-only anniversary stream
Funds raised will benefit The Suzie Mackie Fellowship
Stay updated with breaking news from Triple Negative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Funds raised will benefit The Suzie Mackie Fellowship
According to Houston Methodist researchers who released results on a new combined therapy with the potential to improve outcomes for these hard-to-treat breast cancer patients, a drug used to treat cardiac failure has shown promising results in treating triple-negative breast cancer.
A drug used to treat cardiac failure has shown promising results in treating triple-negative breast cancer, according to Houston Methodist researchers who released results this week on a new combined therapy with the potential to improve outcomes for these hard-to-treat breast cancer patients.
12.12.2021 - Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today presented positive data from its ongoing global Phase 2 clinical ... Seite 1
- Expanded Phase 2 data set continues to provide compelling rationale for move to registrational clinical program - - Bomedemstat demonstrated durable clinical improvement in patients with ET who... | December 12, 2021